Alert: New Earnings Report (11/6/23)-Myriad Genetics Inc (NASDAQ: MYGN).
Myriad Genetics Inc (NASDAQ: MYGN) has reported E.P.S. of $-0.75 for its third fiscal quarter (ending September 30) versus $-0.43 for the same period a year ago. Relative to the consensus estimate of $-0.08, this […]